(Q34277818)

1 August 2017

1 reference

title

Thalidomide in gastrointestinal disorders (English)

1 reference

1 August 2017

0 references

Bousvaros A

1

1 reference

1 August 2017

Mueller B

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

61

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

777-787

1 reference

1 August 2017

cites work

Thalidomide revisited

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes

1 reference

12 December 2020

Pharmacokinetics of thalidomide in an elderly prostate cancer population

1 reference

12 December 2020

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

1 reference

12 December 2020

Thalidomide Responsiveness in an Infant With Behçet's Syndrome

1 reference

12 December 2020

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent

1 reference

12 December 2020

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

12 December 2020

Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement

1 reference

12 December 2020

Treatment of Behçet's disease with thalidomide

1 reference

12 December 2020

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

1 reference

12 December 2020

Thalidomide suppresses Up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4+ T cells in humans

1 reference

12 December 2020

New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide

1 reference

12 December 2020

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

12 December 2020

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

12 December 2020

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

12 December 2020

Long-term remission of Crohn's disease treated with thalidomide: a seminal case report

1 reference

12 December 2020

Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha

1 reference

12 December 2020

Current theories on the causes of inflammatory bowel disease

1 reference

12 December 2020

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

12 December 2020

Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease

1 reference

12 December 2020

Crohn's disease: concordance for site and clinical type in affected family members--potential hereditary influences

1 reference

12 December 2020

Thalidomide is an inhibitor of angiogenesis

1 reference

12 December 2020

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

1 reference

12 December 2020

Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease

1 reference

12 December 2020

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing

1 reference

12 December 2020

Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide

1 reference

12 December 2020

Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

1 reference

12 December 2020

S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide

1 reference

12 December 2020

Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217)

1 reference

12 December 2020

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

1 reference

12 December 2020

Thalidomide: rationale for renewed use in immunological disorders

1 reference

12 December 2020

Thalidomide as salvage therapy for chronic graft-versus-host disease

1 reference

12 December 2020

Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

1 reference

12 December 2020

Longitudinal limb deficiencies and the sclerotomes. An analysis of 378 dysmelic malformations induced by thalidomide

1 reference

12 December 2020

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

1 reference

12 December 2020

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

12 December 2020

Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteer

1 reference

12 December 2020

Thalidomide treatment for chronic graft-versus-host disease

1 reference

12 December 2020

Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Treatment of ulcerative colitis with thalidomide

1 reference

12 December 2020

Inhibition of IL-12 production by thalidomide

1 reference

12 December 2020

Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease

1 reference

12 December 2020

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

12 December 2020

Treatments for wasting in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures

1 reference

12 December 2020

Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers

1 reference

12 December 2020

Single-agent/combination therapy of human immunodeficiency virus-related wasting.

1 reference

12 December 2020

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

1 reference

12 December 2020

Thalidomide as therapy for intestinal chronic GVHD

1 reference

12 December 2020

Thalidomide and recurrent aphthous stomatitis: a follow-up study

1 reference

12 December 2020

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Protein kinase C-dependent effects on leukocyte migration of thalidomide

1 reference

12 December 2020

Thalidomide in Crohn's disease

1 reference

12 December 2020

Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative

1 reference

12 December 2020

Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease

1 reference

12 December 2020

Thalidomide in oral Crohn's disease refractory to conventional medical treatment

1 reference

12 December 2020

Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide

1 reference

12 December 2020

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00003495-200161060-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1019338312

0 references

1 reference